Chronic Obstructive pulmonary Disease Exacerbation. Chronic obstructive pulmonary disease with (acute) exacerbation
Conditions
Interventions
Intervention 1: Intervention group: The other 118 patients, in addition to receiving standard treatment, will be administered ready-to-use vials of inhaled magnesium sulfate via nebulizer at a dose of
Sponsors
Kashan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Individuals with a history of COPD who have been hospitalized due to acute exacerbations Individuals who have been diagnosed with COPD through spirometry Individuals who have an FEV1 of 80% or lower and/or an FEV1/FVC ratio of less than 70%.
Exclusion criteria
Exclusion criteria: Pneumonia Malignancy CHF (Congestive Heart Failure) Astham Hospitalization for a reason other than chronic obstructive pulmonary disease (COPD) exacerbation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Length of Hospital stay. Timepoint: Once, at the time of the patient's discharge. Method of measurement: Patient medical records.;FEV1/FVC. Timepoint: Baseline and after 5 days. Method of measurement: with Spirometry. | — |
Secondary
| Measure | Time frame |
|---|---|
| Admission Interval. Timepoint: Up to 6 month after the primary discharge. Method of measurement: Based on the patient's medical record.;GOLD. Timepoint: On each admission time. Method of measurement: Based on Spirometry and GOLD criteria.;FEV1. Timepoint: Baseline (from the admission) and 5 days after admission. Method of measurement: Spirometry. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAmir Dasdar
Kashan University of Medical Sciences
Outcome results
None listed